Author: Dr.Jessica Giddens

Dr. Jessica Giddens is a distinguished doctorate of nursing practice with a wealth of experience in the mental health field. An INTJ-Asπ (Aspie) or Neurodivergent with Autism, Dr. Giddens has excelled as a speaker, scientific director, thought leader, key opinion leader, consultant, and advisory board member in a wide array of specialties, including but not limited to psychopharmacology, DEI – (A) (diversity, equity, inclusivity, and accessibility), psychopharmacology, bipolar disorder, major depressive disorder, attention deficit disorder, schizophrenia, tardive dyskinesia, pseudobulbar affect, binge eating disorders, autism, neurodiversity, LGBTQIA+ health, social determinants / drivers of health (SDoH), neurodiversity, digital health, digital therapeutics, brain-computer interfaces (and sits as a member of the iBCI Collaborative Community), artificial intelligence, psychopharmacogenomics, epigenetics, sexual health, complex medical psychiatry, chronic care managment, substance use disorder, and genetic testing to name a few. She has worked with psychiatric and genomic research and development companies such as Otsuka, Sumitomo Pharma, Allergan, AbbVie, Teva, Genomind, Nivogenetics, AltheaDx now IDgenetix, and Avanir. In her role as a scientific director with CME Outfitters, she has developed grant-funded CME content and needs assessments for companies, including but not limited to Johnson & Johnson, Pfizer, Alkermes, Indivior, Gilead, and CVS. She was also an integral member for the development of the NP Psych Navigator website.